Best Practices for IND Sponsor Communications: FDA Finalizes Guidance
By Zachary Brennan -
Published 02 January 2018
The US Food and Drug Administration (FDA) last week finalized guidance from 2015 on the best practices for communications between investigational new drug application (IND) sponsors and FDA.
Categories: News, US, FDA, Drugs, Government affairs, Research and development
Tags: IND sponsor communications, FDA guidance, PDUFA